بدائل البحث:
point decrease » point increase (توسيع البحث)
teer decrease » greater decrease (توسيع البحث)
a decrease » _ decrease (توسيع البحث), _ decreased (توسيع البحث), _ decreases (توسيع البحث)
point decrease » point increase (توسيع البحث)
teer decrease » greater decrease (توسيع البحث)
a decrease » _ decrease (توسيع البحث), _ decreased (توسيع البحث), _ decreases (توسيع البحث)
-
15661
-
15662
-
15663
-
15664
The Effect of Catheter Ablation on Left Atrial Size and Function for Patients with Atrial Fibrillation: An Updated Meta-Analysis
منشور في 2015"…Total and subgroup analyses were implemented using Cochrane Review Manager Version 5.2. Weighted mean differences with 95% confidence intervals were used to express the results of continuous outcomes using fixed or random effect models. …"
-
15665
Charge Distribution in Cationic Molybdenum Imido Alkylidene <i>N</i>‑Heterocyclic Carbene Complexes: A Combined X‑ray, XAS, XES, DFT, Mössbauer, and Catalysis Approach
منشور في 2020"…The binding situation in the corresponding cationic complexes Mo(<i>N</i>-2,6-Me<sub>2</sub>C<sub>6</sub>H<sub>3</sub>)(CHCMe<sub>2</sub>Ph)(NHC)(OC(CF<sub>3</sub>)<sub>3</sub>)<sup>+</sup> B(Ar<sup>F</sup>)<sub>4</sub><sup>–</sup> (NHC = IMes (<b>1</b>), IMesCl<sub>2</sub> (<b>2</b>), IMesMe<sub>2</sub> (<b>3</b>), and IMesH<sub>2</sub> (<b>4</b>) was compared to that of the analogous neutral Schrock catalyst Mo(<i>N</i>-2,6-Me<sub>2</sub>C<sub>6</sub>H<sub>3</sub>)(CHCMe<sub>2</sub>Ph)((OC(CF<sub>3</sub>)<sub>3</sub>))<sub>2</sub> (<b>5</b>). Single-crystal X-ray data were used as a starting point for the optimization of the geometries of the catalysts at the PBE0-D3BJ/def2-SVP level of theory; the obtained data were compared to those obtained from X-ray absorption (XAS) and emission spectroscopy (XES). …"
-
15666
Charge Distribution in Cationic Molybdenum Imido Alkylidene <i>N</i>‑Heterocyclic Carbene Complexes: A Combined X‑ray, XAS, XES, DFT, Mössbauer, and Catalysis Approach
منشور في 2020"…The binding situation in the corresponding cationic complexes Mo(<i>N</i>-2,6-Me<sub>2</sub>C<sub>6</sub>H<sub>3</sub>)(CHCMe<sub>2</sub>Ph)(NHC)(OC(CF<sub>3</sub>)<sub>3</sub>)<sup>+</sup> B(Ar<sup>F</sup>)<sub>4</sub><sup>–</sup> (NHC = IMes (<b>1</b>), IMesCl<sub>2</sub> (<b>2</b>), IMesMe<sub>2</sub> (<b>3</b>), and IMesH<sub>2</sub> (<b>4</b>) was compared to that of the analogous neutral Schrock catalyst Mo(<i>N</i>-2,6-Me<sub>2</sub>C<sub>6</sub>H<sub>3</sub>)(CHCMe<sub>2</sub>Ph)((OC(CF<sub>3</sub>)<sub>3</sub>))<sub>2</sub> (<b>5</b>). Single-crystal X-ray data were used as a starting point for the optimization of the geometries of the catalysts at the PBE0-D3BJ/def2-SVP level of theory; the obtained data were compared to those obtained from X-ray absorption (XAS) and emission spectroscopy (XES). …"
-
15667
Charge Distribution in Cationic Molybdenum Imido Alkylidene <i>N</i>‑Heterocyclic Carbene Complexes: A Combined X‑ray, XAS, XES, DFT, Mössbauer, and Catalysis Approach
منشور في 2020"…The binding situation in the corresponding cationic complexes Mo(<i>N</i>-2,6-Me<sub>2</sub>C<sub>6</sub>H<sub>3</sub>)(CHCMe<sub>2</sub>Ph)(NHC)(OC(CF<sub>3</sub>)<sub>3</sub>)<sup>+</sup> B(Ar<sup>F</sup>)<sub>4</sub><sup>–</sup> (NHC = IMes (<b>1</b>), IMesCl<sub>2</sub> (<b>2</b>), IMesMe<sub>2</sub> (<b>3</b>), and IMesH<sub>2</sub> (<b>4</b>) was compared to that of the analogous neutral Schrock catalyst Mo(<i>N</i>-2,6-Me<sub>2</sub>C<sub>6</sub>H<sub>3</sub>)(CHCMe<sub>2</sub>Ph)((OC(CF<sub>3</sub>)<sub>3</sub>))<sub>2</sub> (<b>5</b>). Single-crystal X-ray data were used as a starting point for the optimization of the geometries of the catalysts at the PBE0-D3BJ/def2-SVP level of theory; the obtained data were compared to those obtained from X-ray absorption (XAS) and emission spectroscopy (XES). …"
-
15668
Charge Distribution in Cationic Molybdenum Imido Alkylidene <i>N</i>‑Heterocyclic Carbene Complexes: A Combined X‑ray, XAS, XES, DFT, Mössbauer, and Catalysis Approach
منشور في 2020"…The binding situation in the corresponding cationic complexes Mo(<i>N</i>-2,6-Me<sub>2</sub>C<sub>6</sub>H<sub>3</sub>)(CHCMe<sub>2</sub>Ph)(NHC)(OC(CF<sub>3</sub>)<sub>3</sub>)<sup>+</sup> B(Ar<sup>F</sup>)<sub>4</sub><sup>–</sup> (NHC = IMes (<b>1</b>), IMesCl<sub>2</sub> (<b>2</b>), IMesMe<sub>2</sub> (<b>3</b>), and IMesH<sub>2</sub> (<b>4</b>) was compared to that of the analogous neutral Schrock catalyst Mo(<i>N</i>-2,6-Me<sub>2</sub>C<sub>6</sub>H<sub>3</sub>)(CHCMe<sub>2</sub>Ph)((OC(CF<sub>3</sub>)<sub>3</sub>))<sub>2</sub> (<b>5</b>). Single-crystal X-ray data were used as a starting point for the optimization of the geometries of the catalysts at the PBE0-D3BJ/def2-SVP level of theory; the obtained data were compared to those obtained from X-ray absorption (XAS) and emission spectroscopy (XES). …"
-
15669
Charge Distribution in Cationic Molybdenum Imido Alkylidene <i>N</i>‑Heterocyclic Carbene Complexes: A Combined X‑ray, XAS, XES, DFT, Mössbauer, and Catalysis Approach
منشور في 2020"…The binding situation in the corresponding cationic complexes Mo(<i>N</i>-2,6-Me<sub>2</sub>C<sub>6</sub>H<sub>3</sub>)(CHCMe<sub>2</sub>Ph)(NHC)(OC(CF<sub>3</sub>)<sub>3</sub>)<sup>+</sup> B(Ar<sup>F</sup>)<sub>4</sub><sup>–</sup> (NHC = IMes (<b>1</b>), IMesCl<sub>2</sub> (<b>2</b>), IMesMe<sub>2</sub> (<b>3</b>), and IMesH<sub>2</sub> (<b>4</b>) was compared to that of the analogous neutral Schrock catalyst Mo(<i>N</i>-2,6-Me<sub>2</sub>C<sub>6</sub>H<sub>3</sub>)(CHCMe<sub>2</sub>Ph)((OC(CF<sub>3</sub>)<sub>3</sub>))<sub>2</sub> (<b>5</b>). Single-crystal X-ray data were used as a starting point for the optimization of the geometries of the catalysts at the PBE0-D3BJ/def2-SVP level of theory; the obtained data were compared to those obtained from X-ray absorption (XAS) and emission spectroscopy (XES). …"
-
15670
Charge Distribution in Cationic Molybdenum Imido Alkylidene <i>N</i>‑Heterocyclic Carbene Complexes: A Combined X‑ray, XAS, XES, DFT, Mössbauer, and Catalysis Approach
منشور في 2020"…The binding situation in the corresponding cationic complexes Mo(<i>N</i>-2,6-Me<sub>2</sub>C<sub>6</sub>H<sub>3</sub>)(CHCMe<sub>2</sub>Ph)(NHC)(OC(CF<sub>3</sub>)<sub>3</sub>)<sup>+</sup> B(Ar<sup>F</sup>)<sub>4</sub><sup>–</sup> (NHC = IMes (<b>1</b>), IMesCl<sub>2</sub> (<b>2</b>), IMesMe<sub>2</sub> (<b>3</b>), and IMesH<sub>2</sub> (<b>4</b>) was compared to that of the analogous neutral Schrock catalyst Mo(<i>N</i>-2,6-Me<sub>2</sub>C<sub>6</sub>H<sub>3</sub>)(CHCMe<sub>2</sub>Ph)((OC(CF<sub>3</sub>)<sub>3</sub>))<sub>2</sub> (<b>5</b>). Single-crystal X-ray data were used as a starting point for the optimization of the geometries of the catalysts at the PBE0-D3BJ/def2-SVP level of theory; the obtained data were compared to those obtained from X-ray absorption (XAS) and emission spectroscopy (XES). …"
-
15671
-
15672
-
15673
<b>LINEAR PROGRAMMED DIETARY PLAN DATASET </b><b>ON IMPROVING ENERGY INTAKE AMONG CHILDREN LIVING WITH HIV AGED 2-5 YEARS</b>a
منشور في 2024"…</p><p dir="ltr">There was a significant increase in mean knowledge change (mean change) =2.48(95%CI=1.5-3.3), P=<0.01) as a result of an intervention (F=5.1; P=0.025) with an effect size of (Cohen’s d=0.5{95%CI=0.21-0.78}.The mean change for attitude was 8.49{95%CI=7.02-9.96}, P=<0.001 with significant strength of the intervention F=48.9; P=0.001) with effect size (Cohen’s d =1.2{95%CI=0.87-1.48}.The mean change for energy intake was 351.82(95%CI =303.20-400.44}, P=<0.001) with significant strength of the intervention F=57.95; P=0.001) and effect size (Cohen’s d=1.5(1.29-1.73)</p><p dir="ltr">The intervention effectively increased knowledge and changed attitudes, increasing energy intake among this population.…"
-
15674
Data_Sheet_1_Forced changes in El Niño–Southern Oscillation due to global warming and the associated uncertainties in ACCESS-ESM1.5 large ensembles.docx
منشور في 2022"…There is a modest but statistically significant GW-induced increase in the ensemble-mean ENSO amplitude and a sizable ensemble variation (due to internal variability) with both increases (in 80% of the members) and decreases. …"
-
15675
-
15676
-
15677
Table_1_Five-Year Outcomes of Patients With Mitral Structural Valve Deterioration Treated With Transcatheter Valve in Valve Implantation – A Single Center Prospective Registry.DOCX...
منشور في 2022"…Our cohort consisted of 49 patients (mean age 77.4 ± 10.5 years, 65.3% female). The indications for TM-ViV were mainly for regurgitant pathology (77.6%). …"
-
15678
Image_3_Five-Year Outcomes of Patients With Mitral Structural Valve Deterioration Treated With Transcatheter Valve in Valve Implantation – A Single Center Prospective Registry.JPEG...
منشور في 2022"…Our cohort consisted of 49 patients (mean age 77.4 ± 10.5 years, 65.3% female). The indications for TM-ViV were mainly for regurgitant pathology (77.6%). …"
-
15679
Image_1_Five-Year Outcomes of Patients With Mitral Structural Valve Deterioration Treated With Transcatheter Valve in Valve Implantation – A Single Center Prospective Registry.JPEG...
منشور في 2022"…Our cohort consisted of 49 patients (mean age 77.4 ± 10.5 years, 65.3% female). The indications for TM-ViV were mainly for regurgitant pathology (77.6%). …"
-
15680
Image_2_Five-Year Outcomes of Patients With Mitral Structural Valve Deterioration Treated With Transcatheter Valve in Valve Implantation – A Single Center Prospective Registry.JPEG...
منشور في 2022"…Our cohort consisted of 49 patients (mean age 77.4 ± 10.5 years, 65.3% female). The indications for TM-ViV were mainly for regurgitant pathology (77.6%). …"